Blonanserin: a review of its use in the management of schizophrenia.
about
Profile of blonanserin for the treatment of schizophreniaMoving psychopharmacological drug development to the developing world.Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake.The pharmacokinetic and safety profiles of blonanserin in healthy Chinese volunteers after single fasting doses and single and multiple postprandial doses.Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophreniaTargeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.Clinical Assessment of Weight Gain with Atypical Antipsychotics - Blonanserin vs AmisulprideOne-Year Follow-Up of Serum Prolactin Level in Schizophrenia Patients Treated with Blonanserin: A Case Series.Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.Emerging drugs for schizophrenia.Newer antipsychotics and upcoming molecules for schizophrenia.Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapy.Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities.Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases.Simple and sensitive analysis of blonanserin and blonanserin C in human plasma by liquid chromatography tandem mass spectrometry and its application.Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study.Blonanserin in the treatment of delirium.Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.One-year follow-up study of psychotic patients treated with blonanserin: a case series.
P2860
Q24614169-8A1626C2-2DA3-4C70-B7E2-43BCF8C3B77BQ33692055-704549B9-BA36-40F6-BD17-DA600768C614Q34249753-62E01DCC-9B58-4494-A7AC-DF2A737CB517Q34274859-EC7A4887-6D25-4480-A696-E9D97A397CF6Q34328266-B2895F47-DC93-44DE-BA58-666A224EA530Q34396345-8DCB9928-BBBF-40D3-A136-9EC5FDB93B72Q35007214-CF76D0D4-C090-49EB-9832-707423429D3CQ35071909-F3F36B39-8E24-476D-A1B2-690CF363D12CQ35088447-46755E2E-A012-426E-85CB-8B0A9199B541Q35918105-3ED3C75C-1A5B-4D77-8080-A4A11D23996BQ36205458-A6A1E000-B2F3-4B1F-9D5B-B5610D4B8AACQ37352996-F3D6C1C0-502B-432B-B844-62C025CD5BB3Q37874626-3543BAF4-2E7F-4170-90BE-D39CFD72B013Q38094930-75FC3548-1A8B-4F48-80D9-761D854CCADDQ38168861-3F732417-BECD-4EC9-BECC-B20C48264F6DQ38582539-3C55572D-3C9E-48F5-9A56-57AEC1643342Q39346287-BC3EA657-65E7-40E3-A795-3B6EAD167D40Q40489548-89FEB968-EF31-4047-9AED-A6981524D11BQ41883062-5680D5EF-54DD-4188-BE74-FC8D97C9C0FEQ41997913-0C48EBE7-D262-49D2-8E79-AABBC610BD49Q42395373-1496BB3F-5664-4D21-8887-E72B688D5A96Q45927709-BB5601C8-8816-4FFA-B373-FC1C64EFB1E4Q48076232-4C969677-9684-4CAD-9C79-EA1E83F452E1Q48205983-C17317B1-F50A-4CEB-AD4E-AA1E8DF9B137
P2860
Blonanserin: a review of its use in the management of schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blonanserin: a review of its use in the management of schizophrenia.
@ast
Blonanserin: a review of its use in the management of schizophrenia.
@en
Blonanserin: a review of its use in the management of schizophrenia.
@nl
type
label
Blonanserin: a review of its use in the management of schizophrenia.
@ast
Blonanserin: a review of its use in the management of schizophrenia.
@en
Blonanserin: a review of its use in the management of schizophrenia.
@nl
prefLabel
Blonanserin: a review of its use in the management of schizophrenia.
@ast
Blonanserin: a review of its use in the management of schizophrenia.
@en
Blonanserin: a review of its use in the management of schizophrenia.
@nl
P1433
P1476
Blonanserin: a review of its use in the management of schizophrenia.
@en
P2093
Emma D Deeks
P356
10.2165/11202620-000000000-00000
P577
2010-01-01T00:00:00Z
P6179
1044402442